Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (61-70 of 240) with videos related to

Pageof 24
Sort By:
La Revue De Medecine Interne|August 5, 2000
[A "diagnosis of goldsmith"]L Geffray, J P Poynard, T Collet, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assayM M Bonnay, G Recondo, A J Gouyette, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemiaG Recondo, M Benhamed, E Cvitkovic, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|August 26, 1974
[In vitro inhibition of lymphocyte transformation by various natural cannabinoids]G Nahas, B Desoize, J P Armand, et al.
Pathologie-Biologie|April 1, 1984
[Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis]P Canal, G Villeneuve, R Bugat, et al.
Seminars in Oncology|June 1, 1994
Nasopharyngeal cancer: epidemiology, staging, and treatmentA Fandi, M Altun, N Azli, et al.
Annales De Genetique|January 1, 1988
[The 48,XXXX syndrome: study of psychomotor development from birth to 11 years of age and review of the literature]H Plauchu, E Ollagnon-Roman, J P Armand, et al.
Gastroenterologie Clinique Et Biologique|June 1, 1984
[Budd-Chiari syndrome and congenital antithrombin III deficiency]S Fanello, A Ben Bouali, J Boyer, et al.
Journal Des Maladies Vasculaires|January 1, 1980
[Fistulas and arteriovenous shunts for cytotoxic chemotherapy]A Barret, M Gouzi, J Mason, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.
Pageof 24

Showing results (61-70 of 240) with videos related to

Sort By:
Pageof 24
La Revue De Medecine Interne|August 5, 2000
[A "diagnosis of goldsmith"]L Geffray, J P Poynard, T Collet, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
A new anticancer agent (LY186641) interferes with creatinine assayM M Bonnay, G Recondo, A J Gouyette, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
96-hour continuous infusion of cis-platinum, 5-fluorouracil and bleomycin in recurrent or metastatic head and neck squamous cell carcinoma, unexpected anemiaG Recondo, M Benhamed, E Cvitkovic, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|August 26, 1974
[In vitro inhibition of lymphocyte transformation by various natural cannabinoids]G Nahas, B Desoize, J P Armand, et al.
Pathologie-Biologie|April 1, 1984
[Plasma lactate dehydrogenase and its isoenzymes in nonseminomatous germ cell tumors of the testis]P Canal, G Villeneuve, R Bugat, et al.
Seminars in Oncology|June 1, 1994
Nasopharyngeal cancer: epidemiology, staging, and treatmentA Fandi, M Altun, N Azli, et al.
Annales De Genetique|January 1, 1988
[The 48,XXXX syndrome: study of psychomotor development from birth to 11 years of age and review of the literature]H Plauchu, E Ollagnon-Roman, J P Armand, et al.
Gastroenterologie Clinique Et Biologique|June 1, 1984
[Budd-Chiari syndrome and congenital antithrombin III deficiency]S Fanello, A Ben Bouali, J Boyer, et al.
Journal Des Maladies Vasculaires|January 1, 1980
[Fistulas and arteriovenous shunts for cytotoxic chemotherapy]A Barret, M Gouzi, J Mason, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.
Pageof 24